Screener
Rigel Pharmaceuticals RIGL Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001034842-26-000032
| Line item | As of / March 31, 2026 | As of / December 31, 2025 ⁽¹⁾ |
|---|---|---|
| Short-term investments | 122,273 | 114,375 |
| Accounts receivable, net | 49,945 | 51,763 |
| Inventories | 11,652 | 11,506 |
| Prepaid and other current assets | 25,746 | 21,942 |
| Total current assets | 234,027 | 240,166 |
| Intangible assets, net | 24,160 | 24,748 |
| Deferred income tax asset | 243,279 | 245,852 |
| Operating lease right-of-use assets | 785 | 920 |
Item 1. Financial Statements
FAQ
- What is Rigel Pharmaceuticals's prepaid & other current?
- Rigel Pharmaceuticals (RIGL) reported prepaid & other current of $25.75M in Q1 2026.
- How has Rigel Pharmaceuticals's prepaid & other current changed year-over-year?
- Rigel Pharmaceuticals's prepaid & other current increased by 10.7% year-over-year, from $23.26M to $25.75M.
- What is the long-term trend for Rigel Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's prepaid & other current has grown at a 9.3% compound annual growth rate (CAGR), from $14.05M to $21.94M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Rigel Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude